Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial

Journal of Alzheimer's Disease

Volumn 48, Issue 3, 2015, Pages 793-804

  Di Stefano, Francesca ^a   Epelbaum, Stephane ^a   Coley, Nicola ^b,c,d   Cantet, Christelle ^b,c,d   Ousset, Pierre Jean ^b,c,d   Hampel, Harald ^a,e   Bakardjian, Hovagim ^a   Lista, Simone ^a,e   Vellas, Bruno ^b,c,d   Dubois, Bruno ^a   Andrieu, Sandrine ^b,c,d   Baglio, Francesca ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

Alzheimer's disease; free and cued selective reminding test; IWG criteria; prodromal; subjective cognitive decline

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CATEGORICAL VERBAL FLUENCY; CLINICAL DEMENTIA RATING SUM OF BOXES; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; FREE AND CUED SELECTIVE REMINDING TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PREDICTIVE VALUE; PROGNOSIS; RECALL; SUBJECTIVE COGNITIVE DECLINE; AREA UNDER THE CURVE; COGNITION DISORDERS; LONGITUDINAL STUDY; MENTAL HEALTH; PARASITOLOGY; PERCEPTION; PRODROMAL SYMPTOM; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC;

AGED; ALZHEIMER DISEASE; AREA UNDER CURVE; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MENTAL RECALL; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; PERCEPTION; PRODROMAL SYMPTOMS; PROGNOSIS; ROC CURVE;

EID: 84943738470     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150013     Document Type: Article

References (53)

1. Bolla KI, Lindgren KN, Bonaccorsy C, Bleecker ML (1991) Memory complaints in older adults. Fact or fiction? Arch Neurol 48, 61-64.
2. Ganguli M, Rodriguez E, Mulsant B, Richards S, Pandav R, Bilt JV, Dodge HH, Stoehr GP, Saxton J, Morycz RK, Rubin RT, Farkas B, DeKosky ST (2004) Detection and management of cognitive impairment in primary care: The Steel Valley Seniors Survey. J Am Geriatr Soc 52, 1668-1675.
3. Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chetelat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, Molinuevo JL, Mosconi L, Osorio RS, Perrotin A, Petersen RC, Rabin LA, Rami L, Reisberg B, Rentz DM, Sachdev PS, de la Sayette V, Saykin AJ, Scheltens P, ShulmanMB, Slavin MJ, Sperling RA, Stewart R, Uspenskaya O, Vellas B, Visser PJ, Wagner M, Subjective Cognitive Decline Initiative (SCD-I) Working Group (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement 10, 844-852.
4. Barnes LL, Schneider JA, Boyle PA, Bienias JL, Bennett DA (2006) Memory complaints are related to Alzheimer disease pathology in older persons. Neurology 67, 1581-1585.
5. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, RoweC, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL (2014) Advancing research diagnostic criteria for Alzheimer's disease: The IWG-2 criteria. Lancet Neurol 13, 614-629.
6. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746.
7. Dubois B, Albert ML (2004) Amnestic MCI or prodromal Alzheimer's disease? Lancet Neurol 3, 246-248.
8. Grober E, Buschke H, Crystal H, Bang S, Dresner R (1988) Screening for dementia by memory testing. Neurology 38, 900-903.
9. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9, 1118-1127.
10. Sarazin M, Berr C, De Rotrou J, Fabrigoule C, Pasquier F, Legrain S, Michel B, Puel M, Volteau M, Touchon J, Verny M, Dubois B (2007) Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study. Neurology 69, 1859-1867.
11. Tulving E, Osler S (1968) Effectiveness of retrieval cues in memory for words. J Exp Psychol 77, 593-601.
12. Derby CA, Burns LC, Wang C, Katz MJ, Zimmerman ME, L'Italien G, Guo Z, Berman RM, Lipton RB (2013) Screening for predementia AD: Time-dependent operating characteristics of episodic memory tests. Neurology 80, 1307-1314.
13. Mura T, Proust-Lima C, Jacqmin-Gadda H, Akbaraly TN, Touchon J, Dubois B, Berr C (2014) Measuring cognitive change in subjects with prodromal Alzheimer's disease. J Neurol Neurosurg Psychiatry 85, 363-370.
14. Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues JF, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Andrieu S, GuidAge Study G (2012) Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): A randomised placebo-controlled trial. Lancet Neurol 11, 851-859.
15. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
16. Lipman RS, Covi L (1976) Outpatient treatment of neurotic depression: Medication and group psychotherapy. Proc Annu Meet Am Psychopathol Assoc, 178-218.
17. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, AdeyM, Leirer VO (1982) Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 17, 37-49.
18. Van der Linden M, Coyette F, Poitrenaud J, Kalafat M, Calicis F, Wyns C, Adam S (2004) L'épreuve de rappel libre/rappel indicé á 16 items (RL/RI-16) In L'évaluation des troubles de la mémoire : Présentation de quatre tests de mémoire épisodique avec leur étalonnage, Solal, ed., Marseille, France, pp. 25-47.
19. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140, 566-572.
20. Association AP (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM IV), Washington, DC.
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
22. McNair D, KahnR(1983) Self assessment of cognitive deficit. In Assessment in Clinical Psychopharmacology, Crook T, Ferris A, Baltus R, eds. Mark Powley, New Canaan, CT, pp. 137-143.
23. O'Bryant SE, Lacritz LH, Hall J, Waring SC, ChanW, Khodr ZG, Massman PJ, Hobson V, Cullum CM (2010) Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database. Arch Neurol 67, 746-749.
24. Reitan RM (1958) Validity of the Trail Making Test as an indicator of brain damage. Percept Mot Skills 8, 271-276.
25. Cardebat D, Doyon B, Puel M, Goulet P, Joanette Y (1990) Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level. Acta Neurol Belg 90, 207-217.
26. Lawton MP, Brody EM (1969) Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 9, 179-186.
27. Vellas B, Andrieu S, Ousset PJ, Ouzid M, Mathiex-Fortunet H, GuidAge Study G (2006) The GuidAge study: Methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint. Neurology 67, S6-11.
28. Arevalo-Rodriguez I, Smailagic N, Roque IFM, Ciapponi A, Sanchez-Perez E, Giannakou A, Pedraza OL, Bonfill Cosp X, Cullum S (2015) Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 3, CD010783.
29. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29-36.
30. Ruopp MD, Perkins NJ, Whitcomb BW, Schisterman EF (2008) Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J 50, 419-430.
31. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44, 837-845.
32. Cox DR (1972) Regression models and life tables. J R Stat Soc Ser B 34, 187-220.
33. Altman DG (1991) Analysis of survival times. In Practical Statistics for Medical Research, Altman DG, ed. Chapman & Hall, London, UK, pp. 365-393.
34. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
35. Koepsell TD, Monsell SE (2012) Reversion from mild cognitive impairment to normal or near-normal cognition: Risk factors and prognosis. Neurology 79, 1591-1598.
36. Duara R, Loewenstein DA, Greig MT, Potter E, Barker W, Raj A, Schinka J, Borenstein A, SchoenbergM, Wu Y, Banko J, Potter H (2011) Pre-MCI and MCI: Neuropsychological, clinical, and imaging features and progression rates. Am J Geriatr Psychiatry 19, 951-960.
37. Hendrix SB (2012) Measuring clinical progression in MCI and pre-MCI populations: Enrichment and optimizing clinical outcomes over time. Alzheimers Res The 4, 24.
38. Storandt M, Grant EA, Miller JP, Morris JC (2006) Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology 67, 467-473.
39. Fagan AM, Vos SJ (2013) Preclinical Alzheimer's disease criteria. Lancet Neuro 12, 1134.
40. Sperling R, Mormino E, Johnson K (2014) The evolution of preclinical Alzheimer's disease: Implications for prevention trials. Neuron 84, 608-622.
41. US Food and Drug Administration (2013) Guidance for industry: Alzheimer's disease: Developing drugs for the treatment of early stage disease (draft guidance). US Department of Health and Human Services, http://www. fda. gov/downloads/Drugs/GuidanceComplianceRegulatory Information/Guidances/UCM338287. pdf.
42. Lemos R, Maroco J, Simoes MR, Santiago B, Tomas J, Santana I (2015) The free and cued selective reminding test for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: A prospective longitudinal study. J Neuropsychol. doi: 10. 1111/jnp. 12075
43. Amieva H, Jacqmin-Gadda H, Orgogozo JM, Le Carret N, Helmer C, Letenneur L, Barberger-Gateau P, Fabrigoule C, Dartigues JF (2005) The 9 year cognitive decline before dementia of the Alzheimer type: A prospective populationbased study. Brain 128, 1093-1101.
44. Saxton J, Lopez OL, Ratcliff G, Dulberg C, Fried LP, Carlson MC, Newman AB, Kuller L (2004) Preclinical Alzheimer disease: Neuropsychological test performance 1. 5 to 8 years prior to onset. Neurology 63, 2341-2347.
45. Tierney MC, Yao C, Kiss A, McDowell I (2005) Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 64, 1853-1859.
46. Wagner M, Wolf S, Reischies FM, Daerr M, Wolfsgruber S, Jessen F, Popp J, Maier W, Hull M, Frolich L, Hampel H, Perneczky R, Peters O, Jahn H, Luckhaus C, Gertz HJ, Schroder J, Pantel J, Lewczuk P, Kornhuber J, Wiltfang J (2012) Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology 78, 379-386.
47. Auriacombe S, Helmer C, Amieva H, Berr C, Dubois B, Dartigues JF (2010) Validity of the free and cued selective reminding test in predicting dementia: The 3C study. Neurology 74, 1760-1767.
48. Epelbaum S, Dubois B (2013) Subjective cognitive complaint. From anxiety to prodromal Alzheimer's disease?. Rev Prat 63, 651-654.
49. Grober E, Sanders AE, Hall C, Lipton RB (2010) Free and cued selective reminding identifies very mild dementia in primary care. Alzheimer Dis Assoc Disord 24, 284-290.
50. Grober E, Hall C, Sanders AE, Lipton RB (2008) Free and cued selective reminding distinguishes Alzheimer's disease from vascular dementia. J Am Geriatr Soc 56, 944-946.
51. O'Connell ME, Tuokko H (2010) Age corrections and dementia classification accuracy. Arch Clin Neuropsychol 25, 126-138.
52. Mitchell AJ, Beaumont H, Ferguson D, Yadegarfar M, Stubbs B (2014) Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: Metaanalysis. Acta Psychiatr Scand 130, 439-451.
53. Jelic V, Kivipelto M, Winblad B (2006) Clinical trials in mild cognitive impairment: Lessons for the future. J Neurol Neurosurg Psychiatry 77, 429-438.